Figures & data
Figure 1. LLPS observed with mAb-X and interfered with the downstream manufacturing process. (a) Downstream process flow for mAb-X, purification intermediate solution (at 4oC), and the corresponding solution composition. mg/mL concentration is for mAb-X. The purification intermediates from the grey-shaded steps showed LLPS under the refrigerated conditions. (b) Aggregation rate for mAb-X purification intermediates at different temperatures. (c) Liquid-liquid coexistence curves for mAb-X under the two indicated conditions.
![Figure 1. LLPS observed with mAb-X and interfered with the downstream manufacturing process. (a) Downstream process flow for mAb-X, purification intermediate solution (at 4oC), and the corresponding solution composition. mg/mL concentration is for mAb-X. The purification intermediates from the grey-shaded steps showed LLPS under the refrigerated conditions. (b) Aggregation rate for mAb-X purification intermediates at different temperatures. (c) Liquid-liquid coexistence curves for mAb-X under the two indicated conditions.](/cms/asset/07ca6587-44f4-4ef2-b20f-79144800c145/kmab_a_1599634_f0001_oc.jpg)
Figure 2. The effects of pH and sodium chloride concentration on the LLPS seen with mAb-X purification intermediates (a) Solution behaviors at pH 7.4 with varying sodium chloride concentrations. (b) Solution behaviors at pH 5.0 with varying sodium chloride concentrations. (c) Solution behavior of mAb-X at different pH values without sodium chloride.
![Figure 2. The effects of pH and sodium chloride concentration on the LLPS seen with mAb-X purification intermediates (a) Solution behaviors at pH 7.4 with varying sodium chloride concentrations. (b) Solution behaviors at pH 5.0 with varying sodium chloride concentrations. (c) Solution behavior of mAb-X at different pH values without sodium chloride.](/cms/asset/a5a0db30-ccf7-4b00-8663-3391a7d12ab9/kmab_a_1599634_f0002_oc.jpg)
Figure 3. Mapping the domain of mAb-X associated with LLPS. (a) Solution behavior of full-length mAb-X IgG, F(ab′)2, and Fab. (b) Solutions for mAb-X formatted with different IgG subclasses or light-chain isotypes. (c) Solutions for mAb-X, mAb-Y, and chimeric mAbs. Samples were prepared in 50 mM Tris-HCl, pH 7.4, at approximately 12 mg/mL, and stored at 4ºC for 24 hours.
![Figure 3. Mapping the domain of mAb-X associated with LLPS. (a) Solution behavior of full-length mAb-X IgG, F(ab′)2, and Fab. (b) Solutions for mAb-X formatted with different IgG subclasses or light-chain isotypes. (c) Solutions for mAb-X, mAb-Y, and chimeric mAbs. Samples were prepared in 50 mM Tris-HCl, pH 7.4, at approximately 12 mg/mL, and stored at 4ºC for 24 hours.](/cms/asset/9822c49c-6829-4a3f-a46a-e236d714229e/kmab_a_1599634_f0003_oc.jpg)
Figure 4. Correlation of LLPS with mAb-X self-association. (a) Plot of self-diffusion coefficients against protein concentration to obtain the kD for full mAb-X IgG, F(ab′)2, and Fab. The samples were prepared in 50 mM Tris-HCl, pH 7.4. (b) The effects of sodium chloride on the kD of mAb-X in 50 mM Tris-HCl, pH 7.4. (c) Correlation of kD (obtained by DLS) and plasma shift (obtained by AC-SINS) for seven mAbs.
![Figure 4. Correlation of LLPS with mAb-X self-association. (a) Plot of self-diffusion coefficients against protein concentration to obtain the kD for full mAb-X IgG, F(ab′)2, and Fab. The samples were prepared in 50 mM Tris-HCl, pH 7.4. (b) The effects of sodium chloride on the kD of mAb-X in 50 mM Tris-HCl, pH 7.4. (c) Correlation of kD (obtained by DLS) and plasma shift (obtained by AC-SINS) for seven mAbs.](/cms/asset/a3fa1545-611f-41fe-96df-20a9bbe2a2db/kmab_a_1599634_f0004_oc.jpg)
Table 1. Mutation design for the selected charged CDR residues.
Figure 5. Identification of surface-exposed charged amino acids in the CDRs, based on the homology model. (a) Protein sequences of light chain CDRs for mAb-X and mAb-Y, showing positively (blue) and negatively (red) charged amino acids. (b-c) Molecular surface of mAb-X (b) and mAb-Y (c) Variable fragment homology models generated using the MOE.2016 software package. VL CDR charge amino acids are illustrated on the surface. VH CDR loops are also illustrated.
![Figure 5. Identification of surface-exposed charged amino acids in the CDRs, based on the homology model. (a) Protein sequences of light chain CDRs for mAb-X and mAb-Y, showing positively (blue) and negatively (red) charged amino acids. (b-c) Molecular surface of mAb-X (b) and mAb-Y (c) Variable fragment homology models generated using the MOE.2016 software package. VL CDR charge amino acids are illustrated on the surface. VH CDR loops are also illustrated.](/cms/asset/675f7f7f-56d7-44f7-9e65-d50134e1688b/kmab_a_1599634_f0005_oc.jpg)
Table 2. Molecular properties and self-association behaviors of mAb-X mutants.